Echo IQ Limited logo

Echo IQ Limited (PL4)

Market Open
10 Aug, 20:00
XDUS XDUS
ASX ASX Primary OTC PINK OTC PINK CXA CXA
XDUS XDUS
€
0. 90
+0.01
+1.0045%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
€ 0.9
Previous Close
Add Transaction
Day Range
0.9 0.94
Year Range
0.72 1.03
Want to track PL4 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free

Summary

PL4 trading today higher at €0.9, an increase of 1.0045% from yesterday's close, completing a monthly decrease of -3.6209% or -€0.03. Over the past 12 months, PL4 stock gained 25.6944%.
PL4 is not paying dividends to its shareholders.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0033%, based on the last three reports.
Echo IQ Limited has completed 2 stock splits, with the recent split occurring on Aug 13, 2019.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on ASX (AUD).

PL4 Chart

No Data

Echo IQ Limited (PL4) FAQ

What is the stock price today?

The current price is €0.90.

On which exchange is it traded?

Echo IQ Limited is listed on XDUS.

What is its stock symbol?

The ticker symbol is PL4.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Echo IQ Limited ever had a stock split?

Echo IQ Limited had 2 splits and the recent split was on Aug 13, 2019.

Echo IQ Limited Profile

Software Industry
Information Technology Sector
Mr. Andrew Grover CEO
XDUS Exchange
AU0000195430 ISIN
AU Country
- Employees
- Last Dividend
13 Aug 2019 Last Split
- IPO Date

Overview

Echo IQ Limited is an innovative company focused on the development of artificial intelligence-based diagnostic tools aimed at enhancing the detection and diagnosis of structural heart disease. This technology-centric organization has made significant strides in the healthcare sector within Australia and the United Kingdom by leveraging advanced AI methodologies to aid physicians and health systems in the accurate assessment of heart conditions. Initially known as Houston We Have Limited, the company underwent a rebranding process in December 2021, adopting the name EchoIQ Limited to better reflect its core mission and services. Headquartered in Sydney, Australia, Echo IQ Limited is committed to advancing the field of cardiology diagnostics through its cutting-edge solutions.

Products and Services

  • EchoSolvTM

    • This proprietary software developed by Echo IQ Limited plays a critical role in the identification and diagnosis of Aortic Stenosis, a severe heart condition characterized by the narrowing of the aortic valve opening. EchoSolvTM applies innovative artificial intelligence algorithms to improve the accuracy and efficiency of diagnosing this condition, thereby supporting physicians in developing more effective treatment plans for patients.

Contact Information

Address: U5, 264 Stirling Hwy, Claremont, WA, Australia, 6010
Phone: 61 2 9159 3719
Download app banner
Blog Affiliate Program About Terms Privacy Help Contact Us
2026 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark